Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI
Authors, Journal, Affiliations, Type, DOI
- Carlos Collet, Takuya Mizukami, Frederic Bouisset, Gianluca Pontone, and co-authors for the P4 Trial Investigators; lead site Cardiovascular Research Foundation, New York, with CoreAalst as regulatory sponsor.
- 23 centres in Europe, Asia and North America.
- The New England Journal of Medicine, published November 1, 2026.
- Type: investigator-initiated, international, open-label, randomized, noninferiority trial with blinded endpoint adjudication and hierarchical testing for superiority.
- DOI: 10.1056/NEJMoa2610771. ClinicalTrials.gov: NCT05253677.
- Funded by unrestricted research grants from GE HealthCare and Heartflow to CoreAalst.
Overview
The P4 trial randomized 1,105 patients with stable coronary syndrome or stabilized non-ST-elevation ACS, a ≥70% epicardial lesion and FFR-CT ≤0.80 to a CCTA-guided PCI strategy or IVUS-guided PCI. At 12 months, target-vessel failure occurred in 4.1% with CCTA guidance and 4.6% with IVUS guidance (risk difference −0.42 percentage points, 95% CI −2.82 to 1.99; P<0.001 for noninferiority; P=0.73 for superiority). CCTA guidance also shortened procedures by a median 17 minutes and reduced contrast volume by 20 mL. The trial suggests that selected pre-procedural planning can be shifted from the catheterization laboratory to CT without losing clinical effectiveness, while leaving open the question of how the strategy performs against angiography alone.
Keywords
Coronary CT angiography, FFR-CT, intravascular ultrasound, percutaneous coronary intervention, target-vessel failure, pre-procedural planning, noninferiority, randomized controlled trial
Key Takeaways
Background and Rationale
- Intravascular imaging–guided PCI, particularly IVUS, reduces adverse events compared with angiography guidance and is recommended for complex PCI.
- IVUS requires additional coronary instrumentation and provides information only after catheterization has begun, so procedural decisions are made in real time.
- CCTA with FFR-CT provides noninvasive anatomical and physiological information before the procedure, potentially allowing lesion preparation, stent sizing, landing zones and projections to be planned in advance.
- P4 tested whether a CCTA-guided strategy is noninferior to IVUS-guided PCI for target-vessel failure.
Methods
- Patients aged 18–79 years with chronic coronary syndrome or stabilized non-ST-elevation ACS and a clinical indication for revascularization.
- Eligibility required at least one epicardial lesion with diameter stenosis >70% and FFR-CT ≤0.80 by core laboratory, reference-vessel diameter 2.5–4.0 mm, and no more than two target vessels.
- Exclusions included STEMI, left main disease, previous PCI in the target vessel, previous CABG, eGFR ≤30 mL/min/1.73 m², BMI ≥35 and insufficient CCTA image quality.
- Randomized 1:1 to CCTA-guided PCI or IVUS-guided PCI, stratified by centre.
- CCTA strategy: structured preprocedural planning package (lesion preparation, stent diameter and length, landing zones, optimal projections), intraprocedural 3D CCTA reconstruction synchronized to angiography, prohibition of elective intravascular imaging except bailout, and stent-enhancement imaging for optimization.
- IVUS strategy: IVUS before and after PCI according to prespecified optimization criteria.
- Primary endpoint: target-vessel failure — cardiac death, target-vessel myocardial infarction or ischemia-driven target-vessel revascularization — at 12 months.
- Noninferiority margin: 4.5 percentage points for the absolute risk difference; superiority tested hierarchically if noninferiority was met.
Patients and Procedures
- 1,624 screened, 1,105 randomized March 2022 to August 2025: 556 CCTA-guided and 549 IVUS-guided.
- Median age 65 years; 21.7% women; 20.6% diabetes; 35.8% multivessel disease; 8.5% chronic total occlusion; median SYNTAX score 8–9.
- PCI was the initial strategy in 88.2%, CABG in 3.7% and medical therapy in 8.1%.
- IVUS was performed in 1.0% of the CCTA-guided group (four elective, one bailout); in the IVUS group, IVUS before stenting in 94.7% and after stenting in 93.7%.
- Median procedure duration 46 versus 63 minutes (difference −17.0 minutes, 95% CI −21.0 to −12.0); contrast volume 150 versus 170 mL (difference −20.0 mL, 95% CI −25.0 to 0.0); radiation exposure 35.6 versus 38.5 Gy·cm².
- Additional calcium-modification devices were used more often with CCTA guidance (9.2% versus 3.8%).
Primary Endpoint
- Target-vessel failure at 12 months: 23 patients (4.1%) with CCTA guidance versus 25 (4.6%) with IVUS guidance; risk difference −0.42 percentage points (95% CI −2.82 to 1.99; P<0.001 for noninferiority; P=0.73 for superiority).
- Components: cardiac death 0 versus 2 (0.4%); target-vessel MI 2.9% versus 3.5%; ischemia-driven target-vessel revascularization 1.4% versus 1.5%.
- Per-protocol analysis: 3.8% versus 4.7% (risk difference −0.83 percentage points, 95% CI −3.33 to 1.66).
- Post hoc analysis excluding periprocedural MI: 2.0% in each group (risk difference −0.03 percentage points).
Safety and Secondary Endpoints
- Death from any cause 0.2% versus 0.5%; BARC type 2, 3 or 5 bleeding 1.4% versus 1.3%; BARC type 3 or 5 bleeding 0.4% versus 0.7%.
- Any angiographic complication 2.7% versus 3.0%; clinical procedural complications in 6 versus 9 patients.
- Coronary perforation 0.5% versus 0.2%; vascular access-site complications 0.4% versus 0.5%; periprocedural stroke 0% versus 0.4%.
- Mean invasive FFR after PCI 0.88 in both groups.
- Subgroup analyses were consistent across age, sex, hypertension, dyslipidemia, diabetes, vessel disease and SYNTAX score.
Interpretation
- CCTA-guided PCI was noninferior to IVUS-guided PCI for target-vessel failure and was associated with shorter procedures and lower contrast and radiation exposure during the invasive procedure.
- The trial compared procedural strategies, not imaging methods in isolation: CCTA guidance combined preprocedural anatomical and physiological assessment, structured planning, intraprocedural guidance and stent-enhancement imaging.
- The results support shifting key PCI planning decisions upstream before catheterization in appropriately selected patients.
- The findings do not establish equivalence between CCTA and IVUS, and they should not be extrapolated to left main disease, substantially greater anatomical complexity or CCTA images of insufficient quality.
Limitations of the Document
- The noninferiority margin of 4.5 percentage points was set against an anticipated 7.2% event rate; the observed IVUS event rate was 4.6%, so the absolute margin represented a larger proportion of the control risk than planned.
- The confidence interval is compatible with an absolute benefit of 2.82 percentage points or an excess risk of up to 1.99 percentage points with CCTA guidance.
- Open-label design; operators and patients knew the assigned strategy.
- Women comprised only 21.7% of the population.
- Patients with left main disease, prior CABG, BMI ≥35, severe renal impairment or inadequate CCTA quality were excluded.
- More than half of primary endpoint events were periprocedural myocardial infarctions, and systematic troponin measurement may limit comparison with trials using clinically driven testing.
- Only 4.1% of scans used photon-counting CT; results may change with newer CT technology.
Key Concepts Mentioned
- concepts/CCTA-Guided-PCI — the strategy tested and its evidence base
- concepts/Intracoronary-Imaging-Guided-PCI — IVUS and OCT guidance for PCI
- concepts/Angiography-Based-Coronary-Physiology — FFR-CT and other physiological assessment tools
- concepts/Complete-Revascularization — the broader revascularization framework
- concepts/PCI-Before-TAVI — pre-procedural planning in a related structural population
Key Entities Mentioned
- entities/Chronic-Coronary-Disease — the predominant clinical presentation
- entities/Acute-Coronary-Syndrome — stabilized non-ST-elevation ACS was eligible
- entities/Left-Main-Coronary-Disease — excluded from the trial
Wiki Pages Updated
wiki/sources/CTCA-IVUS-PCI-NEJM-2026.md— created (this file)wiki/concepts/CCTA-Guided-PCI.md— createdwiki/concepts/Intracoronary-Imaging-Guided-PCI.md— updated with the P4 comparisonwiki/concepts/Angiography-Based-Coronary-Physiology.md— updated with FFR-CT planningwiki/concepts/Complete-Revascularization.md— updated with the planning-strategy contextwiki/wikiindex.md— updatedwiki/sourceindex.md— updated